Notwithstanding, Au et al. (19) described a significant association of ABCB1 rs1045642 CC genotype with both major and complete response in a Caucasian cohort of CML patients receiving imatinib. The gene discussed is ABCB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.